DiDi Global (OTCMKTS:DIDIY) and Claritev (NYSE:CTEV) Head-To-Head Comparison

DiDi Global (OTCMKTS:DIDIY) and Claritev (NYSE:CTEV) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

Valuation & Earnings

This table compares DiDi Global and Claritev”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DiDi Global	$31.54 billion	0.57	$137.99 million	$0.03	127.67
Claritev	$965.41 million	0.31	-$284.28 million	($17.30)	-1.05

DiDi Global has higher revenue and earnings than Claritev. Claritev is trading at a lower price-to-earnings ratio than DiDi Global, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares DiDi Global and Claritev’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DiDi Global	0.43%	7.87%	5.03%
Claritev	-29.45%	N/A	-3.96%

Insider & Institutional Ownership

1.8% of DiDi Global shares are held by institutional investors. Comparatively, 87.2% of Claritev shares are held by institutional investors. 9.5% of DiDi Global shares are held by company insiders. Comparatively, 7.4% of Claritev shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of current recommendations for DiDi Global and Claritev, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DiDi Global	0	1	2	1	3.00
Claritev	1	1	3	0	2.40

DiDi Global presently has a consensus target price of $8.60, suggesting a potential upside of 124.54%. Claritev has a consensus target price of $27.00, suggesting a potential upside of 48.84%. Given DiDi Global’s stronger consensus rating and higher probable upside, equities research analysts clearly believe DiDi Global is more favorable than Claritev.

Volatility & Risk

DiDi Global has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, Claritev has a beta of 0.53, indicating that its share price is 47% less volatile than the S&P 500.

Summary

DiDi Global beats Claritev on 13 of the 15 factors compared between the two stocks.

About DiDi Global

DiDi Global Inc. operates a mobility technology platform that provides ride hailing and other services in the People's Republic of China, Brazil, Mexico, and internationally. It offers ride hailing, taxi hailing, chauffeur, hitch, and other forms of shared mobility services; auto solutions comprising leasing, refueling, and maintenance and repair services; electric vehicle leasing services; and bike and e-bike sharing, intra-city freight, food delivery, and financial services. The company was formerly known as Xiaoju Kuaizhi Inc. and changed its name to DiDi Global Inc. in June 2021. DiDi Global Inc. was founded in 2012 and is headquartered in Beijing, China.

About Claritev

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.